"Unconventional" Lyme Disease Treatment May Be Fatal

Staff Writer
Contributor
Posted by Staff WriterJuly 31, 2006 10:37 PM

According to the AP, the FDA warned July 21, that an unconventional treatment for Lyme disease could cause serious injury and even death. Alternative health physicians and others purporting to be doctors prepare and inject into patients a mixture known as bismacine or chromocine, which contains large amounts of heavy metal bismuth. At least one person died while using this product and others have reported serious injuries. One of the primary risks of this product is bismuth poisoning which can cause heart and kidney failure. The FDA approves bismuth for use in some oral drugs used to treat stomach ulcers, but it is not part of any drug permitted for injection. The FDA is investigating the incidents and promise to take appropriate action.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Denver

InjuryBoard Denver RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Denver is brought to you by Bachus & Schanker, LLC

Legal Assistance Center

More Info
Bachus & Schanker, LLC (866) 735-1102 Ext 425 www.coloradolaw.net
google
Personal Injury Lawyers Serving: Denver, Fort Collins, Colorado Spring, Grand Junction, Cheyenne and all surrounding areas. Offices in Denver, Fort Collins and Colorado Springs
1400 16th StreetSuite 450, Denver, Colorado 80202 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address